Antidiabetic medications in overweight/obese patients with type 2 diabetes: drawbacks of current drugs and potential advantages of incretin-based treatment on body weight-Reference-Cited by-同舟云学术

Antidiabetic medications in overweight/obese patients with type 2 diabetes: drawbacks of current drugs and potential advantages of incretin-based treatment on body weight

Published:2007-06-15 Issue: Volume:61 Page:19-28
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:

Author:

Bonora E.

Publisher

Hindawi Limited

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1742-1241.2007.01441.x/fullpdf

Reference118 articles.

1. Diabetes incidence in Pima Indians: contributions of obesity and parental diabetes;Knowler;Am J Epidemiol,1981

2. Obesity, very low density lipoproteins, and glucose intolerance over fourteen years: the Framingham study;Wilson;Am J Epidemiol,1981

3. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study;Bonora;Diabetes,2004

4. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin;Diabetes Prevention Program Research Group;N Engl J Med,2002

5. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance;Tuomilehto;N Engl J Med,2001

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytochemical Profile, Antioxidant, Enzyme Inhibition, Acute Toxicity, In Silico Molecular Docking and Dynamic Analysis of Apis Mellifera Propolis as Antidiabetic Supplement;Chemistry & Biodiversity;2024-05-20

2. Baseline Characteristics Associated With Sodium-Glucose Cotransporter Inhibitor Prescriptions in Type 2 Diabetic Patients in Jazan, Saudi Arabia;Cureus;2022-04-19

3. Exploring biological efficacy of novel benzothiazole linked 2,5-disubstituted-1,3,4-oxadiazole hybrids as efficient α-amylase inhibitors: Synthesis, characterization, inhibition, molecular docking, molecular dynamics and Monte Carlo based QSAR studies;Computers in Biology and Medicine;2021-11

4. Advances in GLP-1 treatment: focus on oral semaglutide;Diabetology & Metabolic Syndrome;2021-09-15

5. Agomelatine protects against obesity-induced renal injury by inhibiting endoplasmic reticulum stress/apoptosis pathway in rats;Toxicology and Applied Pharmacology;2021-08